PURE Bioscience (OTCMKTS:PURE) Rising On News

[[tagnumber 0]][[tagnumber 1]]After PURE Bioscience (OTCMKTS:PURE) experienced a spike in both volume and price back in the beginning of June we have seen the stock’s value slowly dwindle away. The daily volumes also came down and [[tagnumber 2]]PURE[[tagnumber 3]] returned to the illiquid state that it was in the first few months of the year.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]But we can’t really expect that much trading from [[tagnumber 2]]PURE.[[tagnumber 3]] The reason for that is that the company has relatively decent fundamentals and the stock isn’t that volatile. If you take a quick look at the numbers contained in [[tagnumber 2]]PURE’s[[tagnumber 3]] balance sheet for the period ended April 31, 2015 you will see what we are talking about.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 15]] [[tagnumber 16]]cash: $2.53 million[[tagnumber 17]] [[tagnumber 16]]current assets: $2.85 million[[tagnumber 17]] [[tagnumber 16]]current liabilities: $763 thousand[[tagnumber 17]] [[tagnumber 16]]quarterly revenues: $109 thousand[[tagnumber 17]] [[tagnumber 16]]quarterly net loss: $2.09 million[[tagnumber 17]] [[tagnumber 26]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]These numbers surely don’t promise a lot of volatility in the OTC markets. The news coming from the company are also not very promising. [[tagnumber 2]]PURE[[tagnumber 3]] has been issuing press releases concerning the resubmission of their Food Contact Notification and the back and forth communication with the FDA about that matter for several months now.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]The latest press release, however did manage to stir things up a bit. We saw [[tagnumber 2]]PURE[[tagnumber 3]] close two sessions in the green and after yesterday’s 12.89% gain the ticker was sitting at $0.72 per share. The volume was bigger than usual, but the 139 thousand traded shares were only enough to generate $98 thousand in daily dollar volume at those price levels.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Still, considering all the fundamentals of the company we might see it slide once again as the excitement dissipates. Be sure to do your due diligence and weigh out all the risks before attempting any trades.[[tagnumber 4]]